| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/19/2011 | US7981447 Particulate-soluble glucan preparation |
| 07/19/2011 | US7981446 Pharmaceutical compositions and methods for delivering nucleic acids into cells |
| 07/19/2011 | US7981445 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 07/19/2011 | US7981444 Dendritic polymers with enhanced amplification and interior functionality |
| 07/19/2011 | US7981443 Administration of therapeutically effective amount of topiramate over sleep period of patient |
| 07/19/2011 | US7981442 Ultrasound enhancement of drug release across non-ionic surfactant membranes |
| 07/19/2011 | US7981439 Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof |
| 07/19/2011 | US7981435 Spill resistant formulations containing clays |
| 07/19/2011 | US7981401 Diuretic aerosols and methods of making and using them |
| 07/19/2011 | US7981346 Molded micro-needles |
| 07/19/2011 | US7981107 Low profile inlet valve for a piston pump therapeutic substance delivery device |
| 07/19/2011 | US7981106 Electronically-controlled device for release of drugs, proteins, and other organic or inorganic chemicals |
| 07/19/2011 | US7980247 Therapeutic aerosol device |
| 07/19/2011 | US7980243 Two-chamber cartridge for propellant-free metering aerosols |
| 07/19/2011 | CA2690488A1 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
| 07/19/2011 | CA2637774C Nucleosides with anti-hepatitis b virus activity |
| 07/19/2011 | CA2620507C Encapsulated active ingredients, methods of preparation and their use |
| 07/19/2011 | CA2614700C Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 07/19/2011 | CA2578626C Modified-release formulations of a bupropion salt |
| 07/19/2011 | CA2571606C Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 07/19/2011 | CA2570758C Shaped implant material with antibiotic salts |
| 07/19/2011 | CA2565944C Stabilized hyaluronan preparations and related methods |
| 07/19/2011 | CA2509035C Contrast media formulations having improved biological tolerance |
| 07/19/2011 | CA2507579C Pulverulent formulation for inhalation containing tiotropium |
| 07/19/2011 | CA2494015C Antibiotic product, use and formulation thereof |
| 07/19/2011 | CA2483774C Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| 07/19/2011 | CA2481225C Chewing gum in powder form and a method of preparation |
| 07/19/2011 | CA2459329C Infusion device and inlet structure for same |
| 07/19/2011 | CA2459165C Dosage forms having prolonged active ingredient release |
| 07/19/2011 | CA2452239C Pharmaceutical formulation having a masked taste and method for the production thereof |
| 07/19/2011 | CA2434314C Method to enhance the immunogenicity of an antigen |
| 07/19/2011 | CA2431606C Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 07/19/2011 | CA2417388C Therapeutic polyanhydride compounds for drug delivery |
| 07/19/2011 | CA2391439C Brittle-coating, soft core dosage form |
| 07/19/2011 | CA2308584C Targeted liposome gene delivery |
| 07/19/2011 | CA2291740C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 07/19/2011 | CA2188560C Compositions comprising dna damaging agents and p53 |
| 07/14/2011 | WO2011085393A1 Stable insulin formulations and methods of making and using thereof |
| 07/14/2011 | WO2011085356A2 Povidone-iodine and sucrose wound healing dressing |
| 07/14/2011 | WO2011085310A1 A matrix composition for delivery of hydrophobic actives |
| 07/14/2011 | WO2011085298A2 Compositions comprising pigment particles entrapped in collapsed polymeric microspheres, and methods of making the same |
| 07/14/2011 | WO2011085256A2 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
| 07/14/2011 | WO2011085209A2 Methods and compositions for applying moxifloxacin to the ear |
| 07/14/2011 | WO2011085188A1 Pharmaceutical compositions comprising anti-psychotic drugs |
| 07/14/2011 | WO2011085162A2 Topical transdermal dexmedetomidine compositions and methods of use thereof |
| 07/14/2011 | WO2011085158A2 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies |
| 07/14/2011 | WO2011085155A2 Formulations and methods for dissolving cerumen |
| 07/14/2011 | WO2011084967A2 Methods and compositions for providing protective immunity in the elderly |
| 07/14/2011 | WO2011084925A2 Biomaterials made from human hair |
| 07/14/2011 | WO2011084750A1 Antibody formulation |
| 07/14/2011 | WO2011084712A1 Implantable device with intravesical tolerability and methods of treatment |
| 07/14/2011 | WO2011084700A1 Antithrombotic nanoparticle |
| 07/14/2011 | WO2011084668A1 Nestorone®/estradiol transdermal gel |
| 07/14/2011 | WO2011084638A2 Mesalamine suppository |
| 07/14/2011 | WO2011084620A2 Particles for multiple agent delivery |
| 07/14/2011 | WO2011084618A2 Compositions and methods for oral drug delivery |
| 07/14/2011 | WO2011084610A1 Liposomes for preventing the spread of hiv |
| 07/14/2011 | WO2011084593A2 Abuse-resistant formulations |
| 07/14/2011 | WO2011084521A2 Therapeutic polymeric nanoparticles comprising epothilone and methods of making and using same |
| 07/14/2011 | WO2011084518A2 Therapeutic polymeric nanoparticles comprising corticosteroids and methods of making and using same |
| 07/14/2011 | WO2011084513A2 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers |
| 07/14/2011 | WO2011084451A2 Methods and compositions for liquidation of tumors |
| 07/14/2011 | WO2011084376A1 Smoking cessation lozenge containing tobacco alkaloid and silver salt |
| 07/14/2011 | WO2011084316A2 Formulations and methods for controlling mdi particle size delivery |
| 07/14/2011 | WO2011084106A1 Novel amphiphiles |
| 07/14/2011 | WO2011083845A1 Targeting agent for tumor site |
| 07/14/2011 | WO2011083787A1 Anti-inflammatory analgesic adhesive patch for external use |
| 07/14/2011 | WO2011083490A2 Stable veterinary composition for enhanced phosphorous uptake |
| 07/14/2011 | WO2011083428A1 Niosomes, freeze-dried powder thereof and their use in treatment |
| 07/14/2011 | WO2011083402A2 Immediate release compositions of acid labile drugs |
| 07/14/2011 | WO2011083154A1 Dry powder fibrin sealant |
| 07/14/2011 | WO2011083112A2 Solid oral dosage form containing olmesartan medoxomil |
| 07/14/2011 | WO2011083086A1 Functionalised triblock copolymers and compositions containing such polymers |
| 07/14/2011 | WO2011059931A3 Nanosuspension of a poorly soluble drug made by microfluidization process |
| 07/14/2011 | WO2011052884A3 Sustained release tablet containing theobromine |
| 07/14/2011 | WO2011045682A3 Active agent containing polymer network delivery composition and articles using the same |
| 07/14/2011 | WO2011045681A3 Carbohydrate entrapped active agent delivery composition and articles using the same |
| 07/14/2011 | WO2011042568A3 Device and method for reversible office sterilization |
| 07/14/2011 | WO2011036676A3 Stable cocrystals of temozolomide |
| 07/14/2011 | WO2011034323A3 Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system |
| 07/14/2011 | WO2011031819A3 Break resistant gel capsule |
| 07/14/2011 | WO2011031564A3 Methods and systems for dosing and coating inhalation powders onto carrier particles |
| 07/14/2011 | WO2011028016A3 Pharmaceutical preparation comprising beta-adrenergic blockers and angiotensin ii receptor blockers |
| 07/14/2011 | WO2011026094A3 Stable aerosol topical foams comprising a hypochlorite salt |
| 07/14/2011 | WO2011026076A3 Topical formulations comprising a steroid |
| 07/14/2011 | WO2011020933A3 Liposomes covered with the extracellular domain of the apo2l/trail protein |
| 07/14/2011 | WO2011014976A3 Coated senna extract granules |
| 07/14/2011 | WO2010111221A3 Compositions and methods for preferential distribution of active agents to injury sites |
| 07/14/2011 | US20110172771 Hydrogel implant with superficial pores |
| 07/14/2011 | US20110172645 Wearable drug delivery device including integrated pumping and activation elements |
| 07/14/2011 | US20110172591 Portable topical hyperbaric skin therapy and wound treatment system |
| 07/14/2011 | US20110172587 Method and system for drug delivery to the eye |
| 07/14/2011 | US20110172581 Hemostatic compositions and uses therefor |
| 07/14/2011 | US20110172580 Wound care dressing |
| 07/14/2011 | US20110172486 Magnetic microbubbles, methods of preparing them and their uses |
| 07/14/2011 | US20110172249 Method for improving absorbability of preparation, and preparation having improved absorbability |
| 07/14/2011 | US20110172196 Pharmaceutical composition and method for treating hypogonadism |
| 07/14/2011 | US20110171316 Expression and assembly of human group c rotavirus-like particles and uses thereof |
| 07/14/2011 | US20110171315 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/14/2011 | US20110171314 Non-viral compositions and methods for transfecting gut cells in vivo |